Abstract
Left main trunk disease has been increasing over the last few years, and, with it, the usefulness of percutaneous management in some select groups. There are publications showing similar results from percutaneous angioplasty and myocardial revascularization surgery. The advent of new lesion imaging or physiological measurement techniques improves the diagnostic assessment of this disease. Furthermore, the phenomenal evolution of the various stent platforms offers more options for patient interventions. Whatever the context of patients with main trunk disease, it is essential to have a multidisciplinary group in place, in order to offer the best treatment alternative to the appropriate patient.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
